Evidence map›Paper›PMID 41127288›Full record

ArticleFrontiers in neurology2025

Use of nutritional supplements and other complementary medicine methods among patients with Parkinson's disease in Lithuania.

Jevgenija Guk, Rūta Kaladytė Lokominienė, Dalius Jatužis

Abstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jevgenija GukClinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Rūta Kaladytė LokominienėClinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Dalius JatužisClinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: More than half of Parkinson's (PD) disease patients use nutritional supplements and other methods of complementary medicine (CAM). Only a minority discuss their use with their physician. We aimed to evaluate the prevalence and factors associated with using CAM and nutritional supplements among PD patients in Lithuania. Methods: The cross-sectional study was conducted at Vilnius University Hospital Santaros Klinikos in 2022. Patients diagnosed with PD were asked to complete the questionnaire about nutritional supplements and CAMs used during the past 12 months. Results: The data analysis included 169 out of 206 questionnaires. There were 81 (47.9%) males and 88 (52.1%) females. The median age was 66 years old (IQR 59.5-72), and the median duration of PD was 4 years (IQR 2-8). One hundred six patients (62.7%) took nutritional supplements during the last 12 months, and 52 (30.8%) have used some other kind of CAM. Females used such treatment more often than males, respectively, 70.5% vs. 54.3%, Conclusion: Nutritional supplements and CAM therapies are frequently used by PD patients in Lithuania, with a higher prevalence among females. While 67.3% of CAM users discussed their usage with a treating physician or neurologist, only 47.1% of nutritional supplement users did the same. Nevertheless, the latter has a greater potential for interaction with conventional treatments. There is a need to expand the education of general practitioners, neurologists, and PD patients about the indications, effects, and possible side effects of nutritional supplements and other CAM methods, thus raising awareness and encouraging better communication regarding these measures.

Indexed as

CAMcomplementary and alternative medicinenutritional supplementParkinson’s diseaseprevalence

Identifiers

PMID41127288
PMCPMC12537411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.